Xu F, Kong J, Dong SY, Xu L, Wang SH, Sun WB, Gao J. Laparoscopic microwave ablation for giant cavernous hemangioma coexistent with diffuse hepatic hemangiomatosis: Two case reports. World J Gastrointest Surg 2025; 17(3): 101697 [DOI: 10.4240/wjgs.v17.i3.101697]
Corresponding Author of This Article
Wen-Bing Sun, Department of Hepatobiliary Surgery, Beijing Chaoyang Hospital, Capital Medical University, No. 5 Jingyuan Street, Beijing 100043, China. cyhswb@qq.com
Research Domain of This Article
Anthropology
Article-Type of This Article
Case Report
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastrointest Surg. Mar 27, 2025; 17(3): 101697 Published online Mar 27, 2025. doi: 10.4240/wjgs.v17.i3.101697
Laparoscopic microwave ablation for giant cavernous hemangioma coexistent with diffuse hepatic hemangiomatosis: Two case reports
Fei Xu, Jian Kong, Shu-Ying Dong, Li Xu, Shao-Hong Wang, Wen-Bing Sun, Jun Gao
Fei Xu, Jian Kong, Shu-Ying Dong, Li Xu, Shao-Hong Wang, Wen-Bing Sun, Jun Gao, Department of Hepatobiliary Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100043, China
Co-first authors: Fei Xu and Jian Kong.
Co-corresponding authors: Wen-Bing Sun and Jun Gao.
Author contributions: Xu F collected and analyzed data and drafted the manuscript; Kong J and Dong SY were responsible for the perioperative management; Xu F and Kong J contributed equally as co-first authors; Xu L and Wang SH participated in this study; Sun WB critically revised the manuscript; Gao J performed the microwave ablation; Xu F drafted the manuscript; Sun WB and Gao J contributed equally as co-corresponding authors; and all authors agreed to take responsibility for the integrity of the data and the accuracy of data analysis, and approved the final version of the manuscript.
Informed consent statement: All study participants, or their legal guardian, provided informed written consent prior to study enrollment.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Wen-Bing Sun, Department of Hepatobiliary Surgery, Beijing Chaoyang Hospital, Capital Medical University, No. 5 Jingyuan Street, Beijing 100043, China. cyhswb@qq.com
Received: September 23, 2024 Revised: December 7, 2024 Accepted: January 13, 2025 Published online: March 27, 2025 Processing time: 153 Days and 19 Hours
Abstract
BACKGROUND
Hepatic hemangioma represents the most common benign primary hepatic neoplasm. Although most such tumors are small and asymptomatic, giant cavernous hemangioma (GCH) is frequently symptomatic, and needs intervention. Moreover, diffuse hepatic hemangiomatosis (DHH) is not rare in the liver parenchyma adjacent to a GCH. The management strategy for hepatic hemangiomas can differ depending on the presence of associated hemangiomatosis and the amount and distribution of the residual hepatic parenchyma.
CASE SUMMARY
Herein, we report two patients with GCH coexistent with DHH successfully treated by laparoscopic microwave ablation. The two GCHs were ablated completely and the ablated zone atrophied obviously in imaging follow-ups after ablation. Surprisingly, there was a trend toward gradual reduction and diminishment of DHH.
CONCLUSION
Thermal ablation treatment might be an effective and less invasive treatment for GCH coexistent with DHH around the hemangioma.
Core Tip: Hepatic hemangiomas are the most common benign liver tumors, with giant cavernous hemangioma (GCH) often requiring intervention. This report discusses two patients with GCH coexistent with diffuse hepatic hemangiomatosis (DHH), treated successfully with laparoscopic microwave ablation. Both GCHs were completely ablated, showing significant atrophy on follow-up imaging. Notably, there was also a gradual reduction in DHH. These findings suggest that thermal ablation may be an effective and minimally invasive option for managing GCH coexistent with DHH.
